Skip to main content
TipRanks
Go Ultimate75% OFF

Entheon Biomedical (ENBI.X) Financial Statements

17 Followers

Entheon Biomedical Financial Overview

Entheon Biomedical's market cap is currently C$415.77K. The company's EPS TTM is C$-0.01; its P/E ratio is -4.27; Entheon Biomedical has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Feb 26Feb 25Feb 24Feb 23Feb 22
Income Statement
Total RevenueC$ 0.00C$ 0.00C$ 250.32KC$ 189.68KC$ 21.67K
Gross ProfitC$ 0.00C$ 0.00C$ 250.32KC$ 189.68KC$ 9.13K
Operating IncomeC$ -334.22KC$ -333.00KC$ -313.00KC$ -3.60MC$ -8.21M
EBITDAC$ -334.22KC$ -318.00KC$ 13.99KC$ -3.60MC$ -8.21M
Net IncomeC$ -324.01KC$ -318.00KC$ -300.00KC$ -8.52MC$ -8.89M
Balance Sheet
Cash & Short-Term InvestmentsC$ 321.83KC$ 136.49KC$ 344.63KC$ 680.17KC$ 2.05M
Total AssetsC$ 353.78KC$ 185.14KC$ 401.08KC$ 769.22KC$ 9.98M
Total DebtC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Net DebtC$ -321.83KC$ -136.49KC$ -344.63KC$ -680.17KC$ -2.05M
Total LiabilitiesC$ 29.75KC$ 39.81KC$ 85.33KC$ 154.65KC$ 927.71K
Stockholders' EquityC$ 324.03KC$ 145.33KC$ 315.75KC$ 614.57KC$ 9.05M
Cash Flow
Free Cash FlowC$ -314.66KC$ -355.64KC$ -359.93KC$ -1.95MC$ -5.71M
Operating Cash FlowC$ -314.66KC$ -355.64KC$ -359.93KC$ -1.95MC$ -5.62M
Investing Cash FlowC$ 0.00C$ 0.00C$ 24.40KC$ 585.64KC$ -98.87K
Financing Cash FlowC$ 500.00KC$ 147.50KC$ 0.00C$ 0.00C$ 4.98M

Currency in CAD

Entheon Biomedical Earnings and Revenue History

-10M-5M05M-45000 %-30000 %-15000 %0 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin

Entheon Biomedical Liabilities to Assets

04M8M12M0 %12 %24 %36 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets

Entheon Biomedical Cash Flow

-7.5M-5M-2.5M02.5M5M7.5M201720182019202020212022202320242025OperatingInvestingFinancing

Entheon Biomedical Forecast EPS vs Actual EPS

00000000Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26EPS EstimateBeatMiss